Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Thomas M. Ferencz"'
Autor:
Terri L. Parker, Madhav V. Dhodapkar, Daniel Zelterman, Dennis L. Cooper, Geliang Gan, Chandra Sekhar Boddupalli, Stuart Seropian, Randy A. Albrecht, Andrew R. Branagan, Rakesh Verma, Fangyong Li, Eamon Duffy, Thomas M. Ferencz, Lin Zhang
Publikováno v:
Clinical lymphoma, myelomaleukemia. 17(5)
Background Patients with multiple myeloma (MM) and other plasma cell disorders are highly susceptible to influenza infections, which are major causes of morbidity in this population, despite the routine administration of a seasonal influenza vaccinat
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 21(6)
Significant enthusiasm currently exists for new immunotherapeutic strategies: blocking the interaction between programmed death-1 receptor on T-cells and programmed death-ligand 1 on tumor cells to boost immune system stimulation to fight cancer. Imm
Autor:
Lin Zhang, Geliang Gan, Daniel Zelterman, Madhav V. Dhodapkar, Connor Foster, Eamon Duffy, Stuart Seropian, Terri L. Parker, Jeremy S. Kortmansky, Rakesh Verma, David Witt, Debra S. Brandt, Andrew R. Branagan, Thomas M. Ferencz
Publikováno v:
Blood. 128:2139-2139
Background: Plasma cell disorders (PCDs) are commonly associated with immune paresis and these patients are susceptible to common infections, including influenza, which are a major source of morbidity. Although seasonal influenza vaccination is routi
Autor:
Rakesh Verma, Terri L. Parker, Madhav V. Dhodapkar, Stuart Seropian, Dennis L. Cooper, Randy A. Albrecht, Andrew R. Branagan, Eamon Duffy, Chandra Sekhar Boddupall, Xiaopan Yao, Lin Zhang, Thomas M. Ferencz
Publikováno v:
Blood. 126:3058-3058
Background: Patients with plasma cell disorders (PCDs) are among the most susceptible to common infections including influenza and these infections are a major source of morbidity. Although seasonal influenza vaccination is routinely employed in pati
Publikováno v:
Allergy and asthma proceedings. 25(4)
There is a paucity of literature addressing the management of methotrexate (MTX) hypersensitivity. We developed a high-dose MTX readministration protocol based on a modified, prolonged carboplatin desensitization protocol. Over 1.5 hours, 1/1000 of t